Fig. 6
From: Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles
In vivo evaluations of the effect of MLT-HA-HPPS on breast cancer SLN metastasis. a Photos of SLN in different groups after 14 days of treatment. b Quantitative analysis of SLN weight in different groups. c–d Ex vivo fluorescence imaging and quantitative analyze the MFI of each group of resected SLNs after 14 days of tumor treatment. Scale bar: 3 mm. e Confocal imaging detects tfRFP-4T1 tumor cells in different group of SLNs. Blue: DAPI, Red: tfRFP-4T1. Scale bar: 500 μm. Data are shown as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001